The 8th Annual BIO Investor Forum
An International Forum Featuring Late-Stage Private and Emerging Public Companies
October 28-29, 2009
Palace Hotel
San Francisco, CA
Add to Outlook
Investor registration and demand for 1x1 meetings is up in 2009 |
Investor registration and demand for 1x1 meetings at the BIO Investor Forum are up in 2009, reflecting renewed interest in emerging biotech companies. BioCentury reports biotech fundraising in 2009 has already surpassed the whole of 2008. "By the end of last quarter, public fundraising reached $13.1 billion, 56% above the $8.4 billion raised in all of 2008 ... Even IPOs are back on the table." Full story (Click here for more information about BioCentury or for a free trial) |
|
Our new blog that focuses on news and views on deal-making and innovations Recent Posts: |
Advisory Committee
| Benjamin R. Bowen, Ph.D | Rodman & Renshaw, LLC |
| Howard Furst, MD | Deerfield Management |
| John R. Leone | Paul Capital |
| Graeme Martin, Ph.D | Takeda Research Investments, Inc. |
| Evan McCulloch, CFA | Franklin Templeton Investments |
| Oleg Nodelman | Biotechnology Value Fund, LP |
| Heather Preston, MD | TPG Biotech |
| Bryan E. Roberts, Ph.D | Venrock |
| Mark Schoenebaum, MD | Deutsche Bank AG |
| Chris Swindle | Wedbush PacGrow Life Sciences |
| Paul Wagner, Ph.D, CFA | RCM Capital Management, LLC |
Click here to read about the Advisory Committee
Highlights:
- More than 110 late-stage private & emerging public company presentations
- Therapeutic panels led by clinical thought leaders
- Business roundtables addressing key issues affecting biotech executives
- Partnering meetings
- Networking opportunities for investors and industry executives focused exclusively on biotechnology
Who Should Attend
Public and private market investors, research analysts, investment bankers, and industry executives focused on investment and business development opportunities in the life sciences.
Investors attend to:
- hear from and meet with executives at the top life sciences growth companies
- benefit from candid panel discussions with leading clinical experts and investigators with insights on pipeline research and clinical practice
- get a ‘big picture’ overview of the industry and the issues affecting product innovation, capitalization, and commercialization
Companies attend to:
- meet one-on-one with new and current investors, analysts, and partnering companies
- get the pulse on the latest life sciences investment trends from sophisticated investment and company executives
- showcase your company story in presentations to qualified investors
- network with peers, investors and potential partners
The BIO Investor Forum Attracts a Focused Audience
of Biotech Executives and Investors
For more information, please contact customer service:
Email: biopartnering@bio.org
Phone: 866.356.5155, +1.202.962.6666
Please return to this site to view updated information.